NEWS

For our visitors who seek the latest industry news and updates to keep abreast with the goings-on of the business on a global scale, Pharmaceutical Industry portal grants a dynamic and diverse feed of news items.

news

Novelion Therapeutics - unit submitted MAA to EMA seeking approval for metreleptin as replacement therapy to treat complications of leptin deficiency. Novelion Therapeutics Inc - company, through its subsidiary, will seek to market metreleptin in EU under tradename myalepta.   Source: reuters.com

news

Shanghai Fosun Pharmaceutical Group Co Ltd Company and individual shareholders entered into Jiangsu Wanbang share transfer agreement. Individual shareholders agreed to sell and company agreed to purchase Jiangsu Wanbang sale shares for consideration of not more than RMB180 million. Unit Fosun Pharma Industrial and Runjia Sci-Tech entered into Wanbang Jinqiao…

news

Roche Holding AG's emicizumab drug for treating haemophilia A showed it worked in a phase III study, the Swiss drugmaker said on Thursday. Roche is hoping to win a slice of the $11 billion-a-year haemophilia drug market with the drug, also known as ACE910, which represents a threat to more…

news

Colombia's government has lowered the price of Novartis cancer drug imatinib by nearly half in a bid to cut healthcare costs after failed price negotiations with the Swiss company. Novartis will be legally obliged to sell the drug, which is used to treat leukemia and other cancers, at the new…

news

Jubilant Cadista Pharmaceuticals Inc, part of the Jubilant Group, is recalling over 1,500 bottles of glucocorticoid Methylprednisolone tablets in the US market due to incorrect labelling. Jubilant Cadista Pharmaceuticals Inc is recalling 1,512 bottles of Methylprednisolone tablets USP 16 mg, 50-count bottles on account of incorrect labelling, latest Enforcement Report…

news

Drug major, Sun Pharmaceutical today said it plans to acquire branded oncology product Odomzo from Novartis for an upfront payment of $ 175 million. The company, in its regulatory filing to stock exchanges, said the agreement has been signed between the subsidiaries of Sun PharmaBSE 0.49 % and Novartis to…

news

Swiss drug maker Novartis AG said on Tuesday it had reached a definitive agreement to acquire Fort Worth, Texas-based Encore Vision, which is focused on developing a novel treatment in presbyopia, or far-sightedness. "There is a large need for innovative, effective and safe treatment options for people with presbyopia, and…

news

Eyenovia Inc., a clinical-stage ophthalmic pharmaceutical company focused on the discovery, development, and commercialization of first-in-class microtherapeutics for the eye, announces positive results of its Phase II study of the safety and efficacy of its topical piezo-print microtherapeutic approach. The study validates the results of an earlier Phase II trial…

news

Astellas Pharma Inc. announced that it has completed the acquisition of Ganymed Pharmaceuticals AG (“Ganymed”), a biopharmaceutical company located in Mainz, Germany, and Ganymed has become a wholly owned subsidiary of Astellas as of CET December 20, 2016. Under the agreement executed between Astellas and Ganymed’s shareholders, Astellas paid EUR…

news

The U.S. Food and Drug Administration granted accelerated approval to Clovis Oncology Inc's ovarian cancer drug in patients with a specific gene mutation whose disease had advanced despite two or more rounds of chemotherapy. The drug, rubraca, which secured approval about two months earlier than scheduled, targets patients whose tumors…